MeSH Review:
Drug Interactions
- Chemotherapy of L1210 leukemia with 5-azacytidine in combination with vincristine, adriamycin, or beta-cytosine arabinoside. Presant, C.A., Vietti, T.J., Valeriote, F., Coulter, D.M. J. Natl. Cancer Inst. (1981)
- Chemotherapy-induced interstitial pneumonitis during treatment of small cell anaplastic lung cancer. Zimmerman, M.S., Ruckdeschel, J.C., Hussain, M. J. Clin. Oncol. (1984)
- Preirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions. New Approaches to Brain Tumor Therapy Central Nervous System Consortium. Fetell, M.R., Grossman, S.A., Fisher, J.D., Erlanger, B., Rowinsky, E., Stockel, J., Piantadosi, S. J. Clin. Oncol. (1997)
- Dietary advice with or without pravastatin for the management of hypercholesterolaemia associated with protease inhibitor therapy. Moyle, G.J., Lloyd, M., Reynolds, B., Baldwin, C., Mandalia, S., Gazzard, B.G. AIDS (2001)
- Problems associated with medical treatment of peptic ulcer disease. Zimmerman, T.W. Am. J. Med. (1984)
- Indinavir: a review of its use in the management of HIV infection. Plosker, G.L., Noble, S. Drugs (1999)
- Choreoathetosis as a side effect of gabapentin therapy in severely neurologically impaired patients. Chudnow, R.S., Dewey, R.B., Lawson, C.R. Arch. Neurol. (1997)
- Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology. Nordberg, A., Svensson, A.L. Drug safety : an international journal of medical toxicology and drug experience. (1998)
- A risk-benefit assessment of moclobemide in the treatment of depressive disorders. Norman, T.R., Burrows, G.D. Drug safety : an international journal of medical toxicology and drug experience. (1995)
- A review of rivastigmine: a reversible cholinesterase inhibitor. Williams, B.R., Nazarians, A., Gill, M.A. Clinical therapeutics. (2003)
- Drug interaction between thyroxine and lovastatin. Demke, D.M. N. Engl. J. Med. (1989)
- Possible drug interaction during therapy with azidothymidine and acyclovir for AIDS. Bach, M.C. N. Engl. J. Med. (1987)
- A digoxin-antibiotic drug interaction. Doherty, J.E. N. Engl. J. Med. (1981)
- Adenine arabinoside and allopurinol--possible adverse drug interaction. Friedman, H.M. N. Engl. J. Med. (1981)
- Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man. Pettinger, W.A., Mitchell, H.C. N. Engl. J. Med. (1975)
- The effect of allopurinol on cyclophosphamide antitumor activity. Alberts, D.S., van Daalen Wetters, T. Cancer Res. (1976)
- Apparent quinidine-induced digoxin toxicity after withdrawal of pentobarbital: a case of sequential drug interactions. Chapron, D.J., Mumford, D., Pitegoff, G.I. Arch. Intern. Med. (1979)
- Digoxin toxicity and ritonavir: a drug interaction mediated through p-glycoprotein? Phillips, E.J., Rachlis, A.R., Ito, S. AIDS (2003)
- Elucidation of the nifedipine-quinidine interaction. Munger, M.A., Jarvis, R.C., Nair, R., Kasmer, R.J., Nara, A.R., Urbancic, A., Green, J.A. Clin. Pharmacol. Ther. (1989)
- Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir. Hsu, A., Granneman, G.R., Cao, G., Carothers, L., el-Shourbagy, T., Baroldi, P., Erdman, K., Brown, F., Sun, E., Leonard, J.M. Clin. Pharmacol. Ther. (1998)
- The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. Lehmann, J.M., McKee, D.D., Watson, M.A., Willson, T.M., Moore, J.T., Kliewer, S.A. J. Clin. Invest. (1998)
- Valproic acid in epilepsy: clinical and pharmacological effects. Mattson, R.H., Cramer, J.A., Williamson, P.D., Novelly, R.A. Ann. Neurol. (1978)
- Combined effects of 1,25-dihydroxyvitamin D3 and platinum drugs on the growth of MCF-7 cells. Cho, Y.L., Christensen, C., Saunders, D.E., Lawrence, W.D., Deppe, G., Malviya, V.K., Malone, J.M. Cancer Res. (1991)
- Pharmacokinetics of gyrase inhibitors, Part 2: Renal and hepatic elimination pathways and drug interactions. Sörgel, F., Kinzig, M. Am. J. Med. (1993)
- Systematic overview of warfarin and its drug and food interactions. Holbrook, A.M., Pereira, J.A., Labiris, R., McDonald, H., Douketis, J.D., Crowther, M., Wells, P.S. Arch. Intern. Med. (2005)
- CYP3A4 inducible model for in vitro analysis of human drug metabolism using a bioartificial liver. Iwahori, T., Matsuura, T., Maehashi, H., Sugo, K., Saito, M., Hosokawa, M., Chiba, K., Masaki, T., Aizaki, H., Ohkawa, K., Suzuki, T. Hepatology (2003)
- Effects of nicotine on hippocampal and cingulate activity during smooth pursuit eye movement in schizophrenia. Tanabe, J., Tregellas, J.R., Martin, L.F., Freedman, R. Biol. Psychiatry (2006)
- Metabolism of levo-alpha-Acetylmethadol (LAAM) by human liver cytochrome P450: involvement of CYP3A4 characterized by atypical kinetics with two binding sites. Oda, Y., Kharasch, E.D. J. Pharmacol. Exp. Ther. (2001)
- Metabolism and transport of the macrolide immunosuppressant sirolimus in the small intestine. Lampen, A., Zhang, Y., Hackbarth, I., Benet, L.Z., Sewing, K.F., Christians, U. J. Pharmacol. Exp. Ther. (1998)
- Reversal of acquired resistance to adriamycin in CHO cells by tamoxifen and 4-hydroxy tamoxifen: role of drug interaction with alpha 1 acid glycoprotein. Chatterjee, M., Harris, A.L. Br. J. Cancer (1990)
- Potentiation of hypoglycemic effect of sulfonylureas by halofenate. Jain, A.K., Ryan, J.R., McMahon, F.G. N. Engl. J. Med. (1975)
- Membrane surface potential changes may alter drug interactions: an example, acetylcholine and curare. Van der Kloot, W.G., Cohen, I. Science (1979)
- Drug interactions at the GABA receptor-ionophore complex. Olsen, R.W. Annu. Rev. Pharmacol. Toxicol. (1982)
- Carbamazepine-erythromycin interaction. Case studies and clinical significance. Wroblewski, B.A., Singer, W.D., Whyte, J. JAMA (1986)
- Mechanism of the cardiotoxic actions of terfenadine. Woosley, R.L., Chen, Y., Freiman, J.P., Gillis, R.A. JAMA (1993)
- P-glycoprotein and cytochrome P-450 3A inhibition: dissociation of inhibitory potencies. Wandel, C., Kim, R.B., Kajiji, S., Guengerich, P., Wilkinson, G.R., Wood, A.J. Cancer Res. (1999)
- The induction of cytochrome P450 3A5 (CYP3A5) in the human liver and intestine is mediated by the xenobiotic sensors pregnane X receptor (PXR) and constitutively activated receptor (CAR). Burk, O., Koch, I., Raucy, J., Hustert, E., Eichelbaum, M., Brockmöller, J., Zanger, U.M., Wojnowski, L. J. Biol. Chem. (2004)
- Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone. Kharasch, E.D., Hoffer, C., Whittington, D., Sheffels, P. Clin. Pharmacol. Ther. (2004)
- Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor. Burk, O., Arnold, K.A., Nussler, A.K., Schaeffeler, E., Efimova, E., Avery, B.A., Avery, M.A., Fromm, M.F., Eichelbaum, M. Mol. Pharmacol. (2005)
- Oral delivery of anticoagulant doses of heparin. A randomized, double-blind, controlled study in humans. Baughman, R.A., Kapoor, S.C., Agarwal, R.K., Kisicki, J., Catella-Lawson, F., FitzGerald, G.A. Circulation (1998)
- Characterization of human cytochrome P450 enzymes. Guengerich, F.P. FASEB J. (1992)
- Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470. Ma, J., Pulfer, S., Li, S., Chu, J., Reed, K., Gallo, J.M. Cancer Res. (2001)
- Absence of drug interaction between heparin and nitroglycerin. Randomized placebo-controlled crossover study. Bode, V., Welzel, D., Franz, G., Polensky, U. Arch. Intern. Med. (1990)
- Effect of exemestane on tamoxifen pharmacokinetics in postmenopausal women treated for breast cancer. Hutson, P.R., Love, R.R., Havighurst, T.C., Rogers, E., Cleary, J.F. Clin. Cancer Res. (2005)